Search
for
Sort by
Research 30 of 1000+
- Weed Flora and Their Ethnobotanical Importance at Daffodil International University Campus, Bangladesh
- Six weeks finasteride monotherapy before TURP: Does it improve quality of life in early post operative period?
- From Weed to Wonder: Exploring the Multifaceted Pharmacological Actions of Tridax procumbens Linn.
- From Weed to Wonder: Exploring the Multifaceted Pharmacological Actions of Tridax procumbens Linn.
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Cast application of four weeks' duration significantly affects hair length, diameter and density
- Medicinal Value of Three Agricultural Weed Species of the Asteraceae Family: A Review
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- 42175 PASI improvement in the first 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE guselkumab clinical trials
- Hair follicle development and related gene and protein expression of skins in Rex rabbits during the first 8 weeks of life
- Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021
- First Report of ‘<i>Candidatus</i> Phytoplasma aurantifolia’ Associated with the Invasive Weed <i>Eclipta prostrata</i> in Taiwan
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Comparison of Intra-operative Blood Loss in Patients Undergoing Mono-Polar TURP with and without Pre-operative 2 Weeks Use of Finasteride
- Baricitinib Treatment Increases Eyebrow and Eyelash Regrowth Up to 52 Weeks
- Long-term treatment within a maximum of 96 weeks of tinea unguium with long-pulsed neodymium-doped yttrium aluminum garnet laser
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses After 24 and 48 Weeks of Treatment With Ritlecitinib
- Doxetaxel: new indication. Prostate cancer: a few more weeks.
- Antiproliferative and antioxidant potential of Tridax procumbens extracts against various human cancer cell lines: An insight for medicines from weeds
- Selenium levels in new growth hair and in whole blood during ingestion of a selenium supplement for six weeks
- Adalimumab improves health-related quality of life (HRQoL) in patients with moderate to severe hidradenitis suppurativa (HS): Results from the first 12 weeks of PIONEER II
- Developmental changes of skin quality from breast, back, and thigh of Pekin ducks from 1 to 6 weeks of age
- Baricitinib in Alopecia Areata: Real-Life Changes in Lipid Profile and Hematologic Inflammation Indices at 52 weeks
- 44180 Influence of Baseline Disease Severity Defined by Investigator’s Global Assessment on Abrocitinib Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study
- EXPERIENCE OF A PRIVATE HOSPITAL IN THE FEDERAL DISTRICT IN CRYOTHERAPY WITH A HYPOTHERMAL CAP FOR PATIENTS USING PACLITAXEL 80 MG/M² WEEKLY FOR 12 WEEKS
- Comparaison de différentes méthodes de conservation et d'extraction des composés phénoliques dans l'algue marine Ascophyllum Nodosum applicables dans les régions côtières et éloignées = Comparing the effects of different preservation and extraction methods on phenolic compounds in the sea weed Ascophyllum Nodosum applicable to remote coastal communities
- A randomized, blinded, three-arm, multicenter trial comparing the efficacy and safety of fluconazole given once daily for 3 or 6 weeks with griseofulvin given once daily for 6 weeks in pediatric patients with tinea capitis
- A double blind, randomised, vehicle-controlled, safety and tolerance study of topical PSK 3841 solution at 5% administered twice daily over four weeks to healthy Caucasian males with androgenetic alopecia